Astellas Pharma Inc. v. Windlas Healthcare Pvt. Ltd.
1:16-cv-00930
Overview
Parties
Defendant
Windlas Biotech Ltd. Operating Company
Represented By
2 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger
Richards, Layton & Finger, 920 North King Street
Windlas Healthcare Pvt. Ltd. Operating Company
Represented By
5 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger
Richards, Layton & Finger, 920 North King Street
Plaintiff
Astellas Pharma Inc. Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Counter Defendant
Astellas Pharma Global Development Inc. Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Astellas Ireland Co., Ltd. Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 4 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | Asserted Patent | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇯🇵 Japan | Japan Counterpart | View Official Patent → | |
| 🌐 PCT International (WIPO) | PCT World Application | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 4 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7342117
α-form or β-form crystal of acetanilide derivative
|
Filed: 2002-10-20
Issued: 2008-03-11
|
Expired (Term Ended)
+371d PTA
Expires: 2023-10-26
|
|
|
US7982049
α-form or β-form crystal of acetanilide derivative
|
Filed: 2008-01-14
Issued: 2011-07-19
|
Expired (Term Ended)
Expires: 2026-04-07
|
|
|
US8835474
Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
|
Filed: 2011-05-27
Issued: 2014-09-16
|
Active (4.5 yrs remaining)
Expires: 2031-05-27
|
|
|
USRE44872
Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
|
Filed: 2003-11-04
Issued: 2014-04-29
|
Expired (Term Ended)
+44d PTA
Expires: 2023-12-18
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
High PTA (+371 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
3
Dispositive
0
Granted
0
Denied
0
Pending / Review
1
Motions by Category
Key Dispositive Motions & Rulings